Georg Pilz

Publikationen

Publikationen pro Jahr 2007 2008 2010 2011 2012 2013 2014 2015 2016 2017 2018 2020 2021 2022 2023

• 34 Originalarbeit (Zeitschrift)
• 16 publizierter Abstrakt (Zeitschrift)
• 6 Übersichtsarbeit
• 5 Fallbericht
• 5 Mehr
  • 4 Letter to the editor
  • 1 Poster

Publikationen pro Jahr

Publikationen pro Jahr

Suchergebnisse

• 2023

  Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders-A Pilot Study.

  Foettinger, F., Pilz, G. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Harrer, A. (Co-Autor/-in), Kern, J. M. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Moser, T. (Letztautor/-in), 31 März 2023, in: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24, 7

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  2 Quellenangaben (Web of Science)
• 2022

  Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.

  Moser, T. (Erstautor/-in), OSullivan, C. (Co-Autor/-in), Otto, F. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Schwenker, K. (Co-Autor/-in), Mrazek, C. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in) & Harrer, A. (Letztautor/-in), 22 Apr. 2022, in: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 15, S. 17562864221092092

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  6 Quellenangaben (Web of Science)

• Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study.

  Moser, T. (Erstautor/-in), Otto, F. (Co-Autor/-in), O"Sullivan, C. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Harrer, A. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), 24 Jan. 2022, in: Multiple Sclerosis and Related Disorders. 59, S. 103560

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  11 Quellenangaben (Web of Science)
• 2021

  Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine.

  Radlberger, R. F. (Erstautor/-in), Sakic, I., Moser, T. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Harrer, A. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), 2021, in: Multiple Sclerosis and Related Disorders. 48, S. 102727

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  5 Quellenangaben (Web of Science)

• Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy.

  Moser, T. (Erstautor/-in), OSullivan, C., Puttinger, C., Feige, J. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Cadamuro, J. (Co-Autor/-in), Oberkofler, H., Hitzl, W. (Co-Autor/-in), Harrer, A. (Co-Autor/-in), Kraus, J. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), 2021, in: BIOMEDICINES. 9, 11

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  6 Quellenangaben (Web of Science)

• Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.

  Moser, T. (Erstautor/-in), Seiberl, M. (Co-Autor/-in), Feige, J. (Co-Autor/-in), Bieler, L., Radlberger, R. F. (Co-Autor/-in), OSullivan, C., Pilz, G. (Co-Autor/-in), Harrer, A. (Co-Autor/-in), Schwenker, K. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Machegger, L. (Co-Autor/-in), Grimm, J. (Co-Autor/-in), Redlberger-Fritz, M., Buchmann, A., Khalil, M., Kvas, E., Trinka, E. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), Aug. 2021, in: FRONTIERS IN IMMUNOLOGY. 12, S. 718895

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  5 Quellenangaben (Web of Science)

• The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF

  Harrer, C., Otto, F. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Wipfler, P. (Letztautor/-in) & Harrer, A. (Letztautor/-in), 26 Aug. 2021, in: Fluids and Barriers of the CNS. 18, 1, S. 40

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  13 Quellenangaben (Web of Science)
• 2020

  Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases.

  Pilz, G. (Erstautor/-in), Steger, R., Wipfler, P. (Co-Autor/-in), Otto, F. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Harrer, A. (Letztautor/-in), 2020, in: JOURNAL OF NEUROIMMUNOLOGY . 338, S. 577087

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  10 Quellenangaben (Web of Science)

• Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.

  Pilz, G. (Erstautor/-in), Sakic, I., Wipfler, P. (Co-Autor/-in), Kraus, J. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Harrer, A. (Letztautor/-in), 2020, in: Fluids and Barriers of the CNS. 17, 1, S. 7

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  15 Quellenangaben (Web of Science)

• Neurological complications associated with influenza in season 2017/18 in Austria- a retrospective single center study.

  Mylonaki, E., Harrer, A. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Stalzer, P., Otto, F. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), 30 März 2020, in: JOURNAL OF CLINICAL VIROLOGY . 127, S. 104340

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  10 Quellenangaben (Web of Science)
• 2019

  Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.

  Pilz, G. (Erstautor/-in), Wipfler, P. (Co-Autor/-in), Otto, F. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Harrer, A. (Letztautor/-in), 19 Jan. 2019, in: JOURNAL OF NEUROINFLAMMATION. 16, 1, S. 13

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  12 Quellenangaben (Web of Science)

• Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes.

  Leitinger, M. (Erstautor/-in), Trinka, E. (Erstautor/-in), Giovannini, G., Zimmermann, G. J. (Co-Autor/-in), Florea, C., Rohracher, A. (Co-Autor/-in), Kalss, G. (Co-Autor/-in), Neuray, C., Kreidenhuber, R. (Co-Autor/-in), Höfler, J. (Co-Autor/-in), Kuchukhidze, G. (Co-Autor/-in), Granbichler, C., Dobesberger, J. (Co-Autor/-in), Novak, H. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Meletti, S. & Siebert, U., 2019, in: EPILEPSIA. 60, 1, S. 53-62

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  151 Quellenangaben (Web of Science)
• 2018

  Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.

  Rohracher, A. (Erstautor/-in), Kalss, G. (Co-Autor/-in), Neuray, C., Höfler, J. (Co-Autor/-in), Dobesberger, J. (Co-Autor/-in), Kuchukhidze, G. (Co-Autor/-in), Kreidenhuber, R. (Co-Autor/-in), Florea, C., Thomschewski, A. (Co-Autor/-in), Novak, H. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Leitinger, M. (Co-Autor/-in) & Trinka, E. (Letztautor/-in), 2018, in: EPILEPSIA. 59 Suppl 2, S. 234-242

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  29 Quellenangaben (Web of Science)
• 2017

  From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.

  Harrer, A. (Erstautor/-in), Pilz, G. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Sageder, M., Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Rispens, T., de Vries, A., McCoy, M. R. (Co-Autor/-in), Stevanovic, V., Hitzl, W. (Co-Autor/-in), Trinka, E. (Co-Autor/-in), Kraus, J. (Co-Autor/-in), Sellner, J. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), 2017, in: CLINICAL IMMUNOLOGY . 176, S. 87-93

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  5 Quellenangaben (Web of Science)
• 2016

  (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.

  Höfler, J. (Erstautor/-in), Rohracher, A. (Co-Autor/-in), Kalss, G. (Co-Autor/-in), Zimmermann, G. J. (Co-Autor/-in), Dobesberger, J. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Leitinger, M. (Co-Autor/-in), Kuchukhidze, G. (Co-Autor/-in), Butz, K. H. G. (Co-Autor/-in), Taylor, A., Novak, H. (Co-Autor/-in) & Trinka, E. (Letztautor/-in), 2016, in: CNS DRUGS. 30, 9, S. 869-876

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  43 Quellenangaben (Web of Science)

• Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.

  Karamyan, A., Dünser, M. (Co-Autor/-in), Wiebe, D. J., Pilz, G. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Chroust, V. (Co-Autor/-in), Novak, H. (Co-Autor/-in), Hauer, L. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Sellner, J. (Letztautor/-in), 2016, in: PLOS ONE. 11, 5, S. e0155795

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  11 Quellenangaben (Web of Science)
• 2015

  Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

  Harrer, A. (Erstautor/-in), Wipfler, P. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Afazel, S., Kraus, J. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Sellner, J. (Letztautor/-in), 2015, in: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 16, 9, S. 21832-21845

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  6 Quellenangaben (Web of Science)

• High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.

  Harrer, A. (Erstautor/-in), Pilz, G. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Sellner, J. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Afazel, S., Rispens, T., van der Kleij, D., Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2015, in: CLINICAL AND EXPERIMENTAL IMMUNOLOGY . 180, 3, S. 383-392

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  20 Quellenangaben (Web of Science)

• Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.

  Rohracher, A. (Erstautor/-in), Höfler, J. (Co-Autor/-in), Kalss, G. (Co-Autor/-in), Leitinger, M. (Co-Autor/-in), Kuchukhidze, G. (Co-Autor/-in), Deak, I. (Co-Autor/-in), Dobesberger, J. (Co-Autor/-in), Novak, H. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Zerbs, A. (Co-Autor/-in) & Trinka, E. (Letztautor/-in), 2015, in: EPILEPSY & BEHAVIOR : E&B. 49, S. 354-358

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  53 Quellenangaben (Web of Science)

• Predicting outcome of status epilepticus.

  Leitinger, M. (Erstautor/-in), Kalss, G. (Co-Autor/-in), Rohracher, A. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Novak, H. (Co-Autor/-in), Höfler, J. (Co-Autor/-in), Deak, I. (Co-Autor/-in), Kuchukhidze, G. (Co-Autor/-in), Dobesberger, J. (Co-Autor/-in), Wakonig, A. (Co-Autor/-in) & Trinka, E. (Letztautor/-in), 2015, in: EPILEPSY & BEHAVIOR : E&B. 49, S. 126-130

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  37 Quellenangaben (Web of Science)
• 2014

  A routine-qualified flow cytometric method for the identification of multiple sclerosis patients with reduced therapy efficiency under natalizumab

  Oppermann, K. (Erstautor/-in), Harrer, A. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Sellner, J. (Co-Autor/-in), Deisenhammer, F., Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2014, in: LaboratoriumsMedizin-Journal of Laboratory Medicine. 38, 1, S. 17-23

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

• Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

  Wipfler, P. (Erstautor/-in), Harrer, A. (Erstautor/-in), Pilz, G. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Sellner, J. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2014, in: ACTA NEUROLOGICA SCANDINAVICA . 129, 3, S. e12-e15

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  19 Quellenangaben (Web of Science)
• 2013

  Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.

  Harrer, A. (Erstautor/-in), Tumani, H., Niendorf, S., Lauda, F., Geis, C., Weishaupt, A., Kleinschnitz, C., Rauer, S., Kuhle, J., Stangel, M., Weber, F., Uhr, M., Linnebank, M., Wildemann, B., Jarius, S., Guger, M., Ayzenberg, I., Chan, A., Zettl, U. & Wiendl, H. &4 mehr, Pilz, G. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Weber, J. R. & Kraus, J. (Letztautor/-in), 2013, in: MULTIPLE SCLEROSIS . 19, 9, S. 1209-1212

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  60 Quellenangaben (Web of Science)

• Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.

  Wipfler, P. (Erstautor/-in), Heikkinen, A., Harrer, A. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Kunz, A. (Co-Autor/-in), Golaszewski, S. (Co-Autor/-in), Reuss, R., Oschmann, P. & Kraus, J. (Letztautor/-in), 2013, in: JOURNAL OF NEUROLOGY . 260, 1, S. 221-227

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  20 Quellenangaben (Web of Science)

• Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

  Sellner, J. (Erstautor/-in), Koczi, W., Harrer, A. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Obregon-Castrillo, E., Pilz, G. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2013, in: CLINICAL AND EXPERIMENTAL IMMUNOLOGY . 173, 3, S. 381-389

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  25 Quellenangaben (Web of Science)

• Tumefactive MS lesions under fingolimod: a case report and literature review.

  Pilz, G. (Erstautor/-in), Harrer, A. (Erstautor/-in), Wipfler, P. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Sellner, J. (Co-Autor/-in), Fazekas, F., Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2013, in: NEUROLOGY . 81, 19, S. 1654-1658

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  59 Quellenangaben (Web of Science)
• 2012

  Flow cytometry and drug monitoring of natalizumab saturation of immune cells in multiple sclerosis

  Harrer, A. (Erstautor/-in), Oppermann, K. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Afazel, S., Haschke-Becher, L., Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2012, in: LaboratoriumsMedizin-Journal of Laboratory Medicine. 36, 6, S. 377-382

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  2 Quellenangaben (Web of Science)

• Future relevance of CSF biomarkers in modern MS treatment

  Pilz, G. (Erstautor/-in), Wipfler, P. (Erstautor/-in), Harrer, A. (Co-Autor/-in), Holl, B. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Golaszewski, S. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2012, in: LaboratoriumsMedizin-Journal of Laboratory Medicine. 36, 6, S. 383-388

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

• Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.

  Harrer, A. (Erstautor/-in), Pilz, G. (Erstautor/-in), Einhaeupl, M., Oppermann, K. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Sellner, J. (Co-Autor/-in), Golaszewski, S. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2012, in: PLOS ONE. 7, 2, S. e31784

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  19 Quellenangaben (Web of Science)

• Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.

  Pilz, G. (Erstautor/-in), Harrer, A. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in), Golaszewski, S. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2012, in: MULTIPLE SCLEROSIS . 18, 4, S. 506-509

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  9 Quellenangaben (Web of Science)
• 2011

  Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.

  Wipfler, P. (Erstautor/-in), Oppermann, K. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Harrer, A. (Co-Autor/-in), Huemer, M. (Co-Autor/-in), Kunz, A., Golaszewski, S. (Co-Autor/-in), Staffen, W. (Co-Autor/-in), Ladurner, G. & Kraus, J. (Letztautor/-in), 2011, in: MULTIPLE SCLEROSIS . 17, 1, S. 16-23

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  27 Quellenangaben (Web of Science)

• Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.

  Harrer, A. (Erstautor/-in), Wipfler, P. (Erstautor/-in), Einhaeupl, M., Pilz, G. (Co-Autor/-in), Oppermann, K. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Afazel, S., Haschke-Becher, E. (Co-Autor/-in), Strasser, P. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Kraus, J. (Letztautor/-in), 2011, in: JOURNAL OF NEUROIMMUNOLOGY . 234, 1-2, S. 148-154

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  27 Quellenangaben (Web of Science)
• 2010

  Relationship between thrombin generation and carotid intima-media thickness.

  Bernhard, H. (Erstautor/-in), Wipfler, P. (Co-Autor/-in), Leschnik, B., Novak, M., Kraus, J. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Ladurner, G. & Muntean, W., 2010, in: HÄMOSTASEOLOGIE. 30 Suppl 1, S. S168-S171

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

  18 Quellenangaben (Web of Science)
• 2007

  Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells.

  Falkensammer, B., Pilz, G., Bektić, J., Imwidthaya, P., Jöhrer, K., Speth, C., Lass-Flörl, C., Dierich, M. P. & Würzner, R., 2007, in: MYCOSES . 50, 3, S. 172-177

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  15 Quellenangaben (Web of Science)